Tsuyoshi Kojima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tsuyoshi Kojima has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Kazuhiko Shoji
Department of Otolaryngology-Head and Neck Surgery, Tenri Hospital
34 shared publicationsYusuke Okanoue
Department of Otolaryngology Tenri Hospital Nara Japan
25 shared publicationsSatoshi Ikegami
20 shared publicationsAtsuhito Takahashi
17 shared publicationsRyusuke Hori
Department of Otolaryngology ‐ Head and Neck Surgery, School of Medicine University of Occupational and Environmental Health Fukuoka Japan
17 shared publications- Ryusuke Hori
Department of Otolaryngology, Tenri Hospital, Nara, Japan
15 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Wiley in The Laryngoscope
Dynamic and Objective Quantification of Facial Nerve Palsy Using Smartphone‐Based 3D Facial Geometry
Objective: To test whether smartphone‐captured high‐resolution 3D facial geometry can objectively quantify the severity of facial nerve palsy (FNP). Methods: We enrolled 99 patients with peripheral acute unilateral FNP (207 visits) and 12 healthy volunteers (July 2021–February 2024). The facial dynamics were captured using a smartphone with a 3D front‐facing camera, yielding a facial mesh comprising 1220 vertices. Recordings were obtained for multiple facial tasks. Clinical benchmarks included the House–Brackmann (HB) grading and electrophysiology. Features of displacement, velocity, acceleration, and asymmetry were extracted. Random forest regressors were trained for signed continuous HB (side‐aware) score prediction and for region‐specific prediction. Patient‐wise cross‐validation was used. Regressor performance was evaluated using Spearman's ρ , mean absolute error, R 2 , and area under the curve for HB ≥ III. Results: The continuous HB regression model achieved a mean absolute error of 0.718, an R 2 of 0.851, and a Spearman's ρ of 0.935. Predictions for healthy controls were tightly clustered. The area under the receiver operating characteristic curve for screening for HB ≥ III was 0.914 ± 0.052. Region‐specific analyses showed the best performance for eyelid closure and teeth exposure. Regression using integrated electromyography demonstrated moderate correlations, while electroneurography showed weak correlations. Conclusion: Smartphone‐captured high‐frame‐rate 3D facial geometry enabled accurate side‐aware continuous HB estimation and robust screening for clinically significant palsy. This method can detect subtle residual asymmetry beyond human grading, is robust for healthy controls, and may facilitate early detection, standardized monitoring, and at‐home rehabilitation of FNP. Level of Evidence: 3.
- 21 August 2026
- Published by Wiley in The Laryngoscope
Open AccessDynamic and Objective Quantification of Facial Nerve Palsy Using Smartphone‐Based 3D Facial Geometry
Objective: To test whether smartphone‐captured high‐resolution 3D facial geometry can objectively quantify the severity of facial nerve palsy (FNP). Methods: We enrolled 99 patients with peripheral acute unilateral FNP (207 visits) and 12 healthy volunteers (July 2021–February 2024). The facial dynamics were captured using a smartphone with a 3D front‐facing camera, yielding a facial mesh comprising 1220 vertices. Recordings were obtained for multiple facial tasks. Clinical benchmarks included the House–Brackmann (HB) grading and electrophysiology. Features of displacement, velocity, acceleration, and asymmetry were extracted. Random forest regressors were trained for signed continuous HB (side‐aware) score prediction and for region‐specific prediction. Patient‐wise cross‐validation was used. Regressor performance was evaluated using Spearman's ρ , mean absolute error, R 2 , and area under the curve for HB ≥ III. Results: The continuous HB regression model achieved a mean absolute error of 0.718, an R 2 of 0.851, and a Spearman's ρ of 0.935. Predictions for healthy controls were tightly clustered. The area under the receiver operating characteristic curve for screening for HB ≥ III was 0.914 ± 0.052. Region‐specific analyses showed the best performance for eyelid closure and teeth exposure. Regression using integrated electromyography demonstrated moderate correlations, while electroneurography showed weak correlations. Conclusion: Smartphone‐captured high‐frame‐rate 3D facial geometry enabled accurate side‐aware continuous HB estimation and robust screening for clinically significant palsy. This method can detect subtle residual asymmetry beyond human grading, is robust for healthy controls, and may facilitate early detection, standardized monitoring, and at‐home rehabilitation of FNP. Level of Evidence: 3.
- Open Access
- 1 January 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (01) , 001-005
Novel Surgical Approach to Posterior Nasal Neurectomy without Identifying the Posterior Nasal Nerve
Posterior nasal neurectomy (PNN), a procedure used to manage intractable allergic rhinitis, requires precise identification of the posterior nasal nerve and associated neurovascular bundles within the posterior nasal region, including the sphenoid artery. Mastery of reliable surgical techniques and considerable experience are imperative for successful execution. We describe a novel surgical strategy for posterior nasal neurectomy that circumvents the need to directly identify the posterior nasal nerve directly. To clarify the effects of PNN, pre- and post-operative symptoms, including rhinorrhea, sneezing, and nasal obstruction, were evaluated in patients who underwent PNN using scores derived from the Practical Guidelines for Management of Allergic Rhinitis in Japan 2020. Additionally, preoperative and postoperative (>12 months) medication status and postoperative PNN complications were meticulously documented. This retrospective study included 80 patients who underwent PNN between January 2016 and December 2021; 46 of the 80 patients agreed to participate in the survey questionnaire, and the responses of these 46 patients were used for the analysis. Postoperatively, all patients were followed up in the outpatient clinic for >12 months (mean, 18 months). Among the 46 patients, the scores for all allergic symptoms showed significant improvement at 12 months postoperatively compared with the preoperative scores. The proportion of patients who received daily anti-allergic medications decreased from 93.5% (43/46) preoperatively to 15.2% (7/46) postoperatively. No severe complications occurred in any patient. This innovative surgical approach demonstrated efficacy in ameliorating the symptoms associated with allergic rhinitis without concomitantly escalating procedural risks.
- 1 January 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (01) , 001-005
Open AccessNovel Surgical Approach to Posterior Nasal Neurectomy without Identifying the Posterior Nasal Nerve
Posterior nasal neurectomy (PNN), a procedure used to manage intractable allergic rhinitis, requires precise identification of the posterior nasal nerve and associated neurovascular bundles within the posterior nasal region, including the sphenoid artery. Mastery of reliable surgical techniques and considerable experience are imperative for successful execution. We describe a novel surgical strategy for posterior nasal neurectomy that circumvents the need to directly identify the posterior nasal nerve directly. To clarify the effects of PNN, pre- and post-operative symptoms, including rhinorrhea, sneezing, and nasal obstruction, were evaluated in patients who underwent PNN using scores derived from the Practical Guidelines for Management of Allergic Rhinitis in Japan 2020. Additionally, preoperative and postoperative (>12 months) medication status and postoperative PNN complications were meticulously documented. This retrospective study included 80 patients who underwent PNN between January 2016 and December 2021; 46 of the 80 patients agreed to participate in the survey questionnaire, and the responses of these 46 patients were used for the analysis. Postoperatively, all patients were followed up in the outpatient clinic for >12 months (mean, 18 months). Among the 46 patients, the scores for all allergic symptoms showed significant improvement at 12 months postoperatively compared with the preoperative scores. The proportion of patients who received daily anti-allergic medications decreased from 93.5% (43/46) preoperatively to 15.2% (7/46) postoperatively. No severe complications occurred in any patient. This innovative surgical approach demonstrated efficacy in ameliorating the symptoms associated with allergic rhinitis without concomitantly escalating procedural risks.
- 4 September 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (5) , 597-604
Risk factors and timing of postoperative hypothyroidism onset following hemithyroidectomy
- 4 September 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (5) , 597-604
Risk factors and timing of postoperative hypothyroidism onset following hemithyroidectomy
- 2 May 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (9-10) , 398-408
Rat Tracheal Cartilage Regeneration Using Mesenchymal Stem Cells Derived From Human iPS Cells
Tracheal cartilage provides structural support to the airways to enable breathing. However, it can become damaged or impaired, sometimes requiring surgical resection and reconstruction. Previously, we clinically applied an artificial trachea composed of a polypropylene mesh and collagen sponge, with a favorable postoperative course. However, the artificial trachea presents a limitation, as the mesh is not biodegradable and cannot be used in pediatric patients. Compared to a polypropylene mesh, regenerated cartilage represents an ideal material for reconstruction of the damaged trachea. The use of mesenchymal stem cells (MSCs) as a source for cartilage regeneration has gained widespread acceptance, but challenges such as the invasiveness of harvesting and limited cell supply persist. Therefore, we focused on the potential of human-induced pluripotent stem cell (hiPSC)-derived mesenchymal stem cells (iMSCs) for tracheal cartilage regeneration. In this study, we aimed to regenerate tracheal cartilage on an artificial trachea as a preliminary step to replace the polypropylene mesh. iMSCs were induced from hiPSCs through neural crest cells and transplanted with a polypropylene mesh covered with a collagen sponge into the damaged tracheal cartilage in immunodeficient rats. Human nuclear antigen (HNA)-positive cells were observed in all six rats at 4 weeks and in six out of seven rats at 12 weeks after transplantation, indicating that transplanted iMSCs survived within the tracheal cartilage defects of rats. The HNA-positive cells coexpressed SOX9, and type II collagen was detected around HNA-positive cells in four of six rats at 4 weeks and in three of seven rats at 12 weeks after transplantation, reflecting cartilage-like tissue regeneration. These results indicate that the transplanted iMSCs could differentiate into chondrogenic cells and promote tracheal cartilage regeneration. iMSC transplantation thus represents a promising approach for human tracheal reconstruction.
- 2 May 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (9-10) , 398-408
Rat Tracheal Cartilage Regeneration Using Mesenchymal Stem Cells Derived From Human iPS Cells
Tracheal cartilage provides structural support to the airways to enable breathing. However, it can become damaged or impaired, sometimes requiring surgical resection and reconstruction. Previously, we clinically applied an artificial trachea composed of a polypropylene mesh and collagen sponge, with a favorable postoperative course. However, the artificial trachea presents a limitation, as the mesh is not biodegradable and cannot be used in pediatric patients. Compared to a polypropylene mesh, regenerated cartilage represents an ideal material for reconstruction of the damaged trachea. The use of mesenchymal stem cells (MSCs) as a source for cartilage regeneration has gained widespread acceptance, but challenges such as the invasiveness of harvesting and limited cell supply persist. Therefore, we focused on the potential of human-induced pluripotent stem cell (hiPSC)-derived mesenchymal stem cells (iMSCs) for tracheal cartilage regeneration. In this study, we aimed to regenerate tracheal cartilage on an artificial trachea as a preliminary step to replace the polypropylene mesh. iMSCs were induced from hiPSCs through neural crest cells and transplanted with a polypropylene mesh covered with a collagen sponge into the damaged tracheal cartilage in immunodeficient rats. Human nuclear antigen (HNA)-positive cells were observed in all six rats at 4 weeks and in six out of seven rats at 12 weeks after transplantation, indicating that transplanted iMSCs survived within the tracheal cartilage defects of rats. The HNA-positive cells coexpressed SOX9, and type II collagen was detected around HNA-positive cells in four of six rats at 4 weeks and in three of seven rats at 12 weeks after transplantation, reflecting cartilage-like tissue regeneration. These results indicate that the transplanted iMSCs could differentiate into chondrogenic cells and promote tracheal cartilage regeneration. iMSC transplantation thus represents a promising approach for human tracheal reconstruction.
- 2 May 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (9-10) , 361-372
An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells
Investigating the infection mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the airway epithelium and developing effective defense strategies against infection are important. To achieve this, establishing appropriate infection models is crucial. Therefore, various in vitro models, such as cell lines and primary cultures, and in vivo models involving animals that exhibit SARS-CoV-2 infection and genetically humanized animals have been used as animal models. However, no animal model has been established that allows infection experiments with human cells under the physiological environment of airway epithelia. Therefore, we aimed to establish a novel animal model that enables infection experiments using human cells. Human induced pluripotent stem cell-derived airway epithelial cell-transplanted nude rats (hiPSC-AEC rats) were used, and infection studies were performed by spraying lentiviral pseudoviruses containing SARS-CoV-2 spike protein and the GFP gene on the tracheae. After infection, immunohistochemical analyses revealed the existence of GFP-positive-infected transplanted cells in the epithelial and submucosal layers. In this study, a SARS-CoV-2 infection animal model including human cells was established mimicking infection through respiration, and we demonstrated that the hiPSC-AEC rat could be used as an animal model for basic research and the development of therapeutic methods for human-specific respiratory infectious diseases.
- 2 May 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (9-10) , 361-372
An Infection Model for SARS-CoV-2 Using Rat Transplanted with hiPSC-Airway Epithelial Cells
Investigating the infection mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the airway epithelium and developing effective defense strategies against infection are important. To achieve this, establishing appropriate infection models is crucial. Therefore, various in vitro models, such as cell lines and primary cultures, and in vivo models involving animals that exhibit SARS-CoV-2 infection and genetically humanized animals have been used as animal models. However, no animal model has been established that allows infection experiments with human cells under the physiological environment of airway epithelia. Therefore, we aimed to establish a novel animal model that enables infection experiments using human cells. Human induced pluripotent stem cell-derived airway epithelial cell-transplanted nude rats (hiPSC-AEC rats) were used, and infection studies were performed by spraying lentiviral pseudoviruses containing SARS-CoV-2 spike protein and the GFP gene on the tracheae. After infection, immunohistochemical analyses revealed the existence of GFP-positive-infected transplanted cells in the epithelial and submucosal layers. In this study, a SARS-CoV-2 infection animal model including human cells was established mimicking infection through respiration, and we demonstrated that the hiPSC-AEC rat could be used as an animal model for basic research and the development of therapeutic methods for human-specific respiratory infectious diseases.
- 21 April 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (3) , 258-262
Comparison of surgical outcomes between anterograde and retrograde approaches for partial superficial parotidectomy in pleomorphic adenoma: A new surgical technique of the retrograde approach guided by the zygomatic branch
- 21 April 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (3) , 258-262
Comparison of surgical outcomes between anterograde and retrograde approaches for partial superficial parotidectomy in pleomorphic adenoma: A new surgical technique of the retrograde approach guided by the zygomatic branch
- 10 January 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (1) , 59-65
Epidemiological trends in head and neck cancer in Nara Prefecture, Japan, from 2000–2021: The impact of the COVID-19 pandemic
- 10 January 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (1) , 59-65
Epidemiological trends in head and neck cancer in Nara Prefecture, Japan, from 2000–2021: The impact of the COVID-19 pandemic
- 14 June 2024
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (4) , 774-778
Modified method for tracheoesophageal fistula closure in intractable cases
- 14 June 2024
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (4) , 774-778
Modified method for tracheoesophageal fistula closure in intractable cases
- 25 May 2024
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (4) , 713-716
Phonosurgery training using Japanese deer larynx
- 25 May 2024
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (4) , 713-716
Phonosurgery training using Japanese deer larynx
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 561-566
Objective Assessment of Pathological Voice Using Artificial Intelligence Based on the GRBAS Scale
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 561-566
Objective Assessment of Pathological Voice Using Artificial Intelligence Based on the GRBAS Scale